API | adenexanet alfa

adenexanet alfa Report issue

Biologics Recombinant protein Experimental

AACT ChEMBL MeSH

Active Ingredient History

NOW

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
andexanet alfa

More Chemistry

Pharmacology

Mechanisms of Action:
- Coagulation factor X (Homo sapiens) ^UniProt
- Tissue factor pathway inhibitor (Homo sapiens) ^UniProt
Multi-specific: No
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Drug Pricing (per unit)

United States

$16804.0200 - $21447.2400

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

adenexanet alfa | andexanet | andexanet alfa | prt064445 | prt-064445 | prt4445 | prt-4445 | r-antidote | rfxa inhibitor antidote

Organizations (3)

Research & Development (3)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (4)

Approved Indications (1)

Hemorrhage

Experimental Indications - Clinical Trial Phases 1-4 (4)

General Surgery (Phase 3)

Healthy Volunteers (Phase 2)

Hemophilia B ()

Hemorrhage (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial Organizations: 3

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue